Coenzyme biosynthesis in response to precursor availability reveals incorporation of β-alanine from pantothenate in prototrophic bacteria

Autor: Ryback, Birgitta, Vorholt, Julia A.

Publikováno v: In Journal of Biological Chemistry

Regulatory T cells shield muscle mitochondria from interferon-γ–mediated damage to promote the beneficial effects of exercise.

Autor: Langston, P. Kent, Sun, Yizhi, Ryback, Birgitta A., Mueller, Amber L., Spiegelman, Bruce M., Benoist, Christophe, Mathis, Diane

Publikováno v: Science Immunology; 2023, Vol. 8 Issue 89, p1-17, 17p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

TFE3 fusions direct an oncogenic transcriptional program that drives OXPHOS and unveils vulnerabilities in translocation renal cell carcinoma.

Autor: Li J; Department of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA.; Department of Medicine, Harvard Medical School; Boston, MA, USA., Huang K; Department of Medicine, Harvard Medical School; Boston, MA, USA.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., McBride F; Department of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA., Sadagopan A; Department of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA., Gallant DS; Department of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA., Thakur M; Department of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA., Khanna P; Department of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA., Li B; Department of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA.; Department of Medicine, Harvard Medical School; Boston, MA, USA., Ge M; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Weiss CN; Department of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Achom M; Department of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA.; Department of Medicine, Harvard Medical School; Boston, MA, USA., Xu Q; Department of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA., Huang K; Molecular Imaging Core and Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Ryback BA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Gui M; Liangzhu Laboratory, Zhejiang University, Hangzhou 311121, Zhejiang, China; Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, Zhejiang, China., Bar-Peled L; Department of Medicine, Harvard Medical School; Boston, MA, USA.; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Viswanathan SR; Department of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA.; Department of Medicine, Harvard Medical School; Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard; Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital; Boston, MA, USA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Aug 10. Date of Electronic Publication: 2024 Aug 10.